Ga-DOTATATE PET for Localization of Phosphaturic Mesenchymal Tumors in Patients with Tumor Induced Osteomalacia
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 17-008120
NCT ID: NCT03736564
Sponsor Protocol Number: 17-008120
About this study
This study aims to identify cases of FGF23-mediated oncogenic osteoomalacia in which the underlying phosphaturic mesenchymal has not been found and perform 68Ga-DOTATATE PET in these patients to localize the tumor.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Adults (18 years of age or older).
- Seen at Mayo Clinic, Rochester for FGF23 mediated osteomalacia.
- Willing/able to provide informed consent to participate in the study.
Exclusion Criteria:
- Pregnancy.
- Prisoners.
- Subjects diagnosed with heritable hypophosphatemic rickets/osteomalacia.
- Subjects who do not consent for the study or withdraw consent during the duration of the study.
- Subjects in whom tumor localization and successful resection has already occurred.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
Contact |
Rochester, Minn.
Mayo Clinic principal investigator Matthew Drake, M.D., Ph.D. |
Open for enrollment |
Contact information:
Anupam Kotwal M.B.B.S.
|
More information
Publications
Publications are currently not available
Study Results Summary
Not yet available
Supplemental Study Information
Not yet available